Andreja Cerne Cercek

Dr. Andreja Cerne Cercek

Cardiology department, University Medical Center Ljubljana, Ljubljana, Slovenia
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2019 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
PDF file
MIMassimo Imazio
Massimo Imazio
AAAlessandro Andreis
Alessandro Andreis
GFGaetano Maria De Ferrari
Gaetano Maria De Ferrari
PCPaul C Cremer
Paul C Cremer
VMVartan Mardigyan
Vartan Mardigyan
YAYehuda Adler
Yehuda Adler
Novel therapies are needed for recurrent pericarditis, particularly when corticosteroid dependent and colchicine resistant. Based on limited data, interleukin-1 blockade with anakinra may be beneficial. The aim of this multicentre registry was to evaluate the broader effectiveness and safety of anakinra in a ‘real world’ population. This registry enrolled consecutive patients with recurrent pericarditis who were corticosteroid dependent and colchicine resistant and treated with anakinra. The primary outcome was the pericarditis recurrence rate after treatment. Secondary outcomes included emergency department visits, hospitalisations, corticosteroid use and adverse events. Among 224 patients (46 ± 14 years old, 63% women, 75% idiopathic), the median duration of disease was 17 months (interquartile range 9–33). Most patients had elevated C-reactive protein (91%) and pericardial effusion (88%). After a median treatment of 6 months (3–12), pericarditis recurrences were reduced six-fold (2.33–0.39 per patient per year), emergency department admissions were reduced 11-fold (1.08–0.10 per patient per year), hospitalisations were reduced seven-fold (0.99–0.13 per patient per year). Corticosteroid use was decreased by anakinra (respectively from 80% to 27%; P < 0.001). No serious adverse events occurred; adverse events consisted mostly of transient skin reactions (38%) at the injection site. Adverse events led to discontinuation in 3%. A full-dose treatment duration of over 3 months followed by a tapering period of over 3 months were the therapeutic schemes associated with a lower risk of recurrence. In patients with recurrent pericarditis, anakinra appears efficacious and safe in reducing recurrences, emergency department admissions and hospitalisations.

1 July 2021 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
PGPiero Gentile
Piero Gentile
MMMarco Merlo
Marco Merlo
GPGiovanni Peretto
Giovanni Peretto
EAEnrico Ammirati
Enrico Ammirati
SSSimone Sala
Simone Sala
GSGianfranco Sinagra
Gianfranco Sinagra

31 January 2020 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
DBD. Bele
D. Bele
NKNika Kojc
Nika Kojc
MPMartina Perše
Martina Perše
ACAndreja Cerne Cercek
Andreja Cerne Cercek
JLJ. Lindič
J. Lindič
Željka Večerić-HalerŽeljka Večerić-Haler
Željka Večerić-Haler
Background: Diagnosis and treatment of either ANCA disease or silent infection-related glomerulonephritis is complicated and is a huge treatment challenge when overlapping clinical manifestations occur. We report a case of ANCA-PR3 glomerulonephritis, nervous system involvement, hepatosplenomegaly and clinically silent subacute infectious endocarditis. Case presentation: A 57-year-old man with known mitral valve prolaps was admitted for unexplained renal failure with signs of nephritic syndrome, hepatosplenomegaly, sudden unilateral hearing loss, vertigo, malaise, new onset hemolytic anemia and thrombocytopenia. Immunoserology revealed positive c-anti-neutrophil cytoplasm antibody (ANCA)/anti-proteinase 3 (anti-PR3), mixed type crioglobulinemia and lowered complement fraction C3. Head MRI showed many microscopic hemorrhages. Common site of infection, as well as solid malignoma were ruled out. In accordance with clinical and laboratory findings, systemic vasculitis was assumed, although the etiology remained uncertain (ANCA-associated, cryoglobulinemic or related to unrecognized infection). After kidney biopsy, clinical signs of sepsis appeared. Blood cultures revealed Streptococcus cristatus. Echocardiography showed mitral valve endocarditis. Kidney biopsy revealed proliferative, necrotizing immunocomplex glomerulonephritis. Half a year later, following intravenous immunoglobulins, glucocorticoids, antibiotic therapy and surgical valve repair, the creatinine level decreased and c-ANCA and cryoglobulins disappeared. A second kidney biopsy revealed no residual kidney disease. Four years after treatment, the patient is stable with no symptoms or signs of vasculitis recurrence. Conclusions: Here we describe the diagnostic and treatment challenge in a patient with unrecognized subacute bacterial endocarditis associated with ANCA-PR3 immunocomplex proliferative and crescentic glomerulonephritis. In patients with ANCA-PR3 immunocomplex glomerulonephritis and other overlapping manifestations suggesting systemic disease, it is important to recognize and aggressively treat any possible coexisting bacterial endocarditis, This is the most important step for a favorable patient outcome, including complete clinical and pathohistological resolution of the glomerulonephritis.

1 December 2017 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
NPNejc Pavsic
Nejc Pavsic
ZDZvezdana Dolenc-Strazar
Zvezdana Dolenc-Strazar
ACAndreja Cerne Cercek
Andreja Cerne Cercek
TKTomislav Klokocovnik
Tomislav Klokocovnik
KPKatja Prokšelj
Katja Prokšelj

2 November 2020 in Slovenian Medical Journal
Verified
Journal Article
Open access
PDF file
ACAndreja Cerne Cercek
Andreja Cerne Cercek
PBPavel Berden
Pavel Berden
MČMiha Čerček
Miha Čerček
MŠMatjaž Šinkovec
Matjaž Šinkovec
The pericardium may be affected as an isolated process or as part of a systemic disease. In developed countries (with a low prevalence of tuberculosis), the most common aetiologies are presumed to be viral, immune-mediated forms (systemic inflammatory diseases, post-cardiac injury syndromes) and cancer. In clinical practice, there are few general presentations with distinctive signs and symptoms that are referred to as pericardial syndromes: pericarditis, isolated pericardial effusion, cardiac tamponade, constrictive pericarditis and pericardial masses and cysts. In the latest European Society of Cardiology guidelines for pericardial disease new diagnostic strategies have been proposed for the triage of patients with pericarditis and pericardial effusion, and specific diagnostic criteria have been established for acute and recurrent pericarditis. Moreover, new therapeutic strategies have emerged. The article covers a translation of ESC Guidelines on the Diagnosis and Management of Pericardial Diseases adapted to our situation.

22 December 2023 in Applied Sciences
Verified
Journal Article
Open access
PDF file
LKLana Kralj
Lana Kralj
ACAndreja Cerne Cercek
Andreja Cerne Cercek
ANAlja Gomišček Novak
Alja Gomišček Novak
BKBorut Kirn
Borut Kirn
Background: Myocardial damage in myocarditis is assessed through late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR). Variability in quantifying myocarditis extent results from imprecise image segmentation and inconclusive data on quantification method selection. To improve analysis precision, segmentation steps are systematically ranked based on their inherent risks of error. Additionally, data on two distinct quantification methods are presented. Methods: Using newly developed software, four experts analyzed five LGE-CMR left ventricular (LV) short-axis (SAx) images of myocarditis patients in three sessions. Regions of interest (ROIs) (myocardial (ROImyoc), reference (ROIref), and exclusion region (ROIexcl)) were identified and used to calculate LGE extent with 3σ (intensity above three standard deviations (σ) in reference) and the full width at half maximum (FWHM) method (intensity above 50% of maximum signal in reference). The reference LGE extent was calculated and the influence of the ROIs on LGE extent variability was determined. Interobserver and intraobserver variability were evaluated as 1-intraclass correlation coefficient (ICC). Results: LGE extent variability was 6.2 ± 0.6% for 3σ and 4.0 ± 0.6% for FWHM. The contributions of ROImyoc, ROIref, and ROIexcl were 1.5 ± 0.2%, 2.7 ± 0.4%, and 2 ± 0.3%, respectively, for 3σ, and 1.1 ± 0.1%, 1.6 ± 0.4%, and 1.3 ± 0.3%, respectively, for FWHM. LGE extent was lower in FWHM. Interobserver variability was 0.56 for 3σ and 0.43 for FWHM. The intraobserver variability was higher for the 3σ method in all four observers. Conclusion: ROIref selection contributed most to LGE extent variability. FWHM yielded lower LGE extent and lower inter- and intraobserver variability. Due to low statistical significance, the findings are only partially confirmed.